We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

57 hedge funds and large institutions have $2.93M invested in Envoy Medical Warrant in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

6% more capital invested

Capital invested by funds: $2.77M → $2.93M (+$166K)

2% more funds holding

Funds holding: 56 → 57 (+1)

Holders
57
Holders Change
+1
Holders Change %
+1.79%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
2
Closed
5
Calls
$6.11M
Puts
–
Net Calls
+$6.11M
Net Calls Change
-$889K

Top Buyers

Rank Fund Capital Flow
1
Man Group
Man Group
United Kingdom
+$25.3K
2
BCM
BlueCrest Capital Management
Jersey
+$9.05K
3
CAC
Cowen and Company
New York
+$6.03K
4
SCM
Shaolin Capital Management
Florida
+$3.87K
5
PC
Periscope Capital
Ontario, Canada
+$2.26K

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$22K
2
EH
EMG Holdings
Connecticut
-$14K
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$8.39K
4
Capstone Investment Advisors
Capstone Investment Advisors
New York
-$8K
5
CC
Centiva Capital
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.64M – – –
SCM
2
Segantii Capital Management
Hong Kong
$491K – – –
AC
3
Athos Capital
Hong Kong
$328K – – –
MP
4
Mangrove Partners
Connecticut
$109K +$1.01K +11,143 New
AC
5
Aristeia Capital
Connecticut
$52K – – –
Nomura Holdings
6
Nomura Holdings
Japan
$33K – – –
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$20K – – –
PC
8
Periscope Capital
Ontario, Canada
$20K +$2.26K +25,000 +9%
ETH
9
Exos TFP Holdings
New York
$17K +$23.5K +259,235 New
FTCM
10
Fir Tree Capital Management
New York
$15K – – –
SCM
11
Shaolin Capital Management
Florida
$14K +$3.87K +42,753 +26%
BCM
12
BlueCrest Capital Management
Jersey
$13K +$9.05K +100,001 +100%
WA
13
Whitebox Advisors
Minnesota
$12K – – –
SC
14
Sculptor Capital
New York
$11K – – –
RA
15
Ramius Advisors
New York
$11K +$905 +10,000 +6%
Man Group
16
Man Group
United Kingdom
$10K +$25.3K +279,455 New
CS
17
Clear Street
New York
$9K – – –
RIA
18
RP Investment Advisors
Ontario, Canada
$9K – – –
Goldman Sachs
19
Goldman Sachs
New York
$8K – – –
Parallax Volatility Advisers
20
Parallax Volatility Advisers
California
$7K -$8.39K -92,754 -48%
AC
21
Antara Capital
New York
$7K – – –
TCA
22
Taconic Capital Advisors
New York
$7K – – –
MC
23
Meteora Capital
Florida
$7K +$1.36K +15,000 +16%
CCA
24
Castle Creek Arbitrage
Colorado
$6K – – –
KL
25
KIM LLC
Kansas
$6K – – –
1
2 3

COCHW Hedge Fund Activity: Q3 2022 in Review

57 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q3 2022, worth a combined $2.93M — up 6% from $2.77M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new COCHW positions and 5 closed out — a net gain of 1 holder — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Man Group, opening a new position worth an estimated $25.3K. The largest seller was Woodline Partners, exiting entirely with an estimated $22K sold.

  • 57 institutional investors held Envoy Medical Warrant (COCHW) as of Q3 2022, up from 56 in Q2 2022.
  • Funds reported $2.93M of Envoy Medical Warrant stock for Q3 2022, up 6% quarter-over-quarter.
  • 6 funds opened new Envoy Medical Warrant positions in Q3 2022 and 5 closed out, a net change of +1 holder.
  • The largest Envoy Medical Warrant buyer in Q3 2022 was Man Group, an estimated $25.3K added.
  • The largest Envoy Medical Warrant seller in Q3 2022 was Woodline Partners, an estimated $22K sold.

Based on aggregated 13F filings for Q3 2022.